The global GLP-1 market is projected to reach approximately $133 billion by 2030
Peptides work synergistically with proper nutrition, exercise, sleep, and stress managementnot as replacements for these fundamentals
Implications for retail pharmacies and GLP-1 drugmakers: For older GLP-1 patients, Walmarts combination of everyday convenience and obesity support services offers an easy on-ramp to treatment where theyre already shopping
Dhatariya K, Bain SC, Buse JB et al (2018) The impact of liraglutide on diabetes-related foot ulceration and associated complications in patients with type 2 diabetes at high risk for cardiovascular events: results from the LEADER trial
The Ultimate Weight Loss Peptide Blend: SLU-PP-332, 5-Amino-1MQ, and BPC-157 Peptides are transforming the way we approach fat loss, metabolic health, and healing